Characterization of high affinity IgM and IgG monoclonal antibodies against norovirus variants GII .4 and GII .17
Protein Science · 2026-04 · 35 (4)
DOI: 10.1002/pro.70522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 12.03.2026. Verfasst von Jumpei Tagawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Norovirus, Immunoglobulin M, Immunoglobulin G, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency, Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Human noroviruses are a leading cause of acute gastroenteritis worldwide, yet the molecular principles governing antibody recognition of their highly repetitive capsid remain poorly understood. Here, we immunized mice with virus‐like particles (VLPs) from the pandemic GII.4 strain and the emergent GII.17 strain, generating monoclonal IgM and IgG antibodies via hybridoma technology. High‐speed atomic force microscopy visualized IgM antibodies scanning and engaging multiple protruding (P) domains on intact VLPs. Surface plasmon resonance (SPR) analyses of engineered antibodies with identical Fab sequences but different valencies revealed that, unlike monovalent IgG, multivalent IgM exhibits dramatic affinity gains—up to 100‐fold—as antigen density increases. This avidity‐driven enhancement arises from the dense, repetitive P‐domain architecture of the norovirus capsid, enabling IgM to achieve high functional affinity despite modest intrinsic Fab binding. Our findings define how antibody valency and epitope organization cooperate to boost viral recognition, offering a mechanistic framework for designing next‐generation vaccines and antiviral antibodies that harness multivalent engagement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
- Laboratory for Materials and Structures, Institute of Integrated research, Institute of Science Tokyo, Kanagawa, Japan.
- Laboratory of Creative Science for Insect Industries, Kyushu University Graduate School of Bioresource and Bioenvironmental Sciences, Fukuoka, Japan.
- Department of Biological Science and Technology, Tokyo University of Science, Tokyo, Japan.
- Graduate School of Sciences, Nagoya University, Nagoya, Aichi, Japan.
- Laboratory of Insect Genome Science, Kyushu University Graduate School of Bioresource and Bioenvironmental Sciences, Fukuoka, Japan.
ORCID-Profile: Saeko Yanaka, Akinobu Senoo, Jose M M Caaveiro
Förderung
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences
Zitieren
APA
Tagawa, J., Yanaka, S., Kato, Y., Masuda, A., Lee, J. M., Senoo, A., Oyama, K., Uchihashi, T., Nishida, M., Kusakabe, T., & Caaveiro, J. M. M. (2026). Characterization of high affinity IgM and IgG monoclonal antibodies against norovirus variants GII .4 and GII .17. Protein Science, 35(4). https://doi.org/10.1002/pro.70522
Vancouver
Tagawa J, Yanaka S, Kato Y, Masuda A, Lee JM, Senoo A, et al. Characterization of high affinity IgM and IgG monoclonal antibodies against norovirus variants GII .4 and GII .17. Protein Science. 2026;35(4). doi:10.1002/pro.70522
BibTeX
@article{Tagawa2026,
author = {Tagawa, Jumpei and Yanaka, Saeko and Kato, Yuri and Masuda, Akitsu and Lee, Jae Man and Senoo, Akinobu and Oyama, Kosuke and Uchihashi, Takayuki and Nishida, Motohiro and Kusakabe, Takahiro and Caaveiro, Jose M M},
title = {Characterization of high affinity IgM and IgG monoclonal antibodies against norovirus variants GII .4 and GII .17},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {4},
doi = {10.1002/pro.70522}
}
EUVIMED